New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients

By Zuccotti Gianna   Strasfeld Lynne   Weinstock David M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1669-1679

Informa Healthcare

Access to resources Recommend Favorite

A double‐blind, randomized, controlled trial on N‐acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 2, 2015-06 ,pp. : 67-74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

By Shimoni Avichai   Volchek Yulia   Koren-Michowitz Maya   Varda-Bloom Nira   Somech Raz   Shem-Tov Noga   Yerushalmi Ronit   Nagler Arnon  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 863-871

Blackwell Publishing

Access to resources Recommend Favorite

Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 30-47

Bentham Science Publishers

Access to resources Recommend Favorite

Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 69-76

Bentham Science Publishers

Access to resources Recommend Favorite